Name: Latest research reports of Dr. Lal Pathlabs Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Dr. Lal Pathlabs Ltd.
Rating: 3
Author: Geojit BNP Paribas

Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Strong Performer, Getting Expensive

3100.0000 -77.20 (-2.43%)

NSE Aug 04, 2025 15:31 PM

35.16% Gain from 52W Low

Volume: 91,619

Dr. Lal Pathlabs Ltd.

25 May 2021

3100.00

-2.43%

DR. LAL PATHLABS LIMITED

Hold: Dr. Lal Pathlabs Ltd.

Target

Geojit BNP Paribas

Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. Company has 231 clinical laboratories, including National Reference Lab at Delhi and Regional...

Emkay released a Buy report for Dr. Lal Pathlabs Ltd. with a price target of 3100.0 on 20 Jul, 2025.